MAPT and Alzheimer disease: Patients with typical AD demonstrated variability in entorhinal and neocortical tau binding; however, in a cluster analysis comparing high and low uptake groups, those with high entorhinal and neocortical tracer retention showed greatest memory impairment, whilst those with low entorhinal and high neocortical binding showed greatest impairment in other neuropsychological domains.